About La Trobe    Faculties    Campuses    Teaching & Learning    Research    International   
La Trobe home

Science Technology & Engineering

Bypass navigation and go to content

Home
About Us
Contact Us
Course Information
Feedback
Graduate Careers
Our Research

Molecular Virology

Contaminants in Human Milk

Our Staff
Seminars
Site Map
Web Links


Dr John May retired from human milk research in 2006 and the last entry was made in December 2005. While this page and the related tables will be kept online, they will only be updated sporadically in the future, if at all.

Department of Microbiology
Human milk - Tables of the antimicrobial factors and microbiological contaminants relevant to human milk banking

Over the last few years less continuing interest has been taken in the factors present in human milk that are shown to protect infants from microbial infections (particularly with respiratory or gastrointestinal infection). More recent interest has centred on the presence in human milk of new viruses.

Epidemiological studies have been important in demonstrating that breast feeding clearly protects infants against respiratory and gastointestinal infections, or decreases the severity of these infections. Breastfeeding can also protect against otitis media (middle ear infection), pneumonia, diarrhoea, necrotizing enterocolitis and sepsis. The primary protective factors in breast milk are the presence of specific antibody and anti-adhesion factors in human milk. However, a variety of antimicrobial factors (antiviral, antibacterial and antiparasitic) have been detected in human milk over the years (see Tables 1,2,3). Most of these factors are not destroyed by pasteurisation (62.5°C for 30 minutes) (see Table 7).

Microbial contaminants in human milk (Table 4) are rare, as are the associated infant infections from the milk. However, some contaminants, such as cytomegalovirus, are commonly transferred to infants from seropositive mothers, fortunately without adverse effects in infants. Human T-lymphotropic virus type 1 is transferred via human milk in endemic regions, while human immunodeficiency virus type 1 is also transferred through human milk - but is not the exclusive mode of transmission to infants. Pasteurisation (62.5°C for 30 minutes) has been shown to destroy all microbial contaminants in human milk (except hepatitis B, which is fortunately not transferred through milk). With the use of new detection technology, low levels of some viruses have been found in human milk, but no epidemiological evidence suggest any transfer of these viruses from mother-to-infant via human milk. If a mother and infant have the same virus infection, and even in some cases if that virus is detected in the mother's milk, the milk may not be the source of the virus transmission to the infant (Table 4). Detection of virus nucleic acid does not mean enveloped viruses, in particular, are still infectious in human milk. Various bacterial contaminants present in expressed human milk have caused infections (Table 5). Infections of infants have occasionally occurred from bacterial contaminants in dried milk formula (Table 6). The effect of heat treatment and storage of human milk on some the antimicrobial factors is given in Table 7.

The Human Milk Banking Association of North America guidelines are for the donors of human milk to have negative blood tests for human immunodeficiency virus type 1 and 2; syphilis; hepatitis B and C; and human T lymphotropic virus type 1 and 2. Temporary exclusion may occur if the donor is infected with rubella, has had an attenuated virus vaccine (ie. rubella), cold sore virus (herpes simplex virus) or chickenpox virus (varicella-zoster), or mastitis. The milk collected should contain no pathogenic bacteria (Staphylococcus aureus, group B streptococci, Pseudomonas aeruginosa, and lactose-fermenting coliforms), or no more than 100,000 colony forming units per millilitre of normal skin bacteria and contain no viable bacteria after pasteurisation.

Human milk contains a variety of potential anti-inflammatory agents, immunomodulators and bioactive compounds that may influence the incidence of diarrhoea in infected infants.

Table 1: Antibacterial factors found in human milk
Table 2: Antiviral factors found in human milk
Table 3: Antiparasite factors found in human milk
Table 4: Microbial contaminants or nucleic acid detected in human milk
Table 5: Isolated contaminants from expressed human milk that caused infection
Table 6: Contaminants in infant formula that caused infections
Table 7: Effect of heat treatment and storage on antimicrobial factors in human milk

References

  • J.K. Welsh and J.T. May (1979). Anti-infective properties of breast milk. J. Pediatrics. 94, 1-9.
  • J.T. May (1984). Anti-microbial properties and microbial contaminants of breast milk - an update. Aust. Ped. J. 20, 265-269.
  • J.T. May (1988). Microbial contaminants and anti-microbial properties of human milk. Microbiol. Sciences. 5, 42-46.
  • J.T. May (1994). Anti-microbial factors and microbial contaminants in human milk. J. Ped. Child Health. 30, 470-475.
  • J.T. May (1995). Human milk - anti-microbial and microbial contaminants relevant to human milk banking. In Breast milk and special case nurseries: problems and opportunities. ALCA press. Melbourne. pp19-24.
  • J.T. May (1997). Clinical significance and recent studies of the anti-infective properties and infectious contaminants in breast milk, In "Breast feeding: The natural advantage". NMAA press: Sydney. pp. 138-144.
  • A, Inglis, J.T. May and C. Lighton (1998). Fact sheets on the web: A case study of the on-line dissemination of information on the anti- infective properties of breast milk. Contemporary Nurse. 7, 91-97.
  • J.T. May (1999). Breast milk and infection - a brief overview. Breastfeeding review. 7, 25-27.

Related Information

  • A summary of whether or not it is okay to breastfeed in the USA with infectious diseases, medication, or environmental contaminants is given in R.M. Lawrence and R.A. Lawrence (2001) Given the benefits of breastfeeding, what contraindications exist? Pediatrics Clinics of North America. 48, 235-251.
  • R. A. Lawrence (1997) A review of the medical benefits and contraindications to breastfeeding in the United States. Maternal & Child Health Technical Information Bulletin (Online http://www.ncemch.org/pubs/PDFs/breastfeedingTIB.pdf)
  • A summary of whether it is okay to breastfeed with known infectious microbial contaminants is also given in C.A. Jones (2001) Maternal transmission of infectious pathogens in breast milk. Journal of Paediatric and Child Health. 37, 576-582.
  • Recommendations of whether it is okay to breastfeed with virus contaminants is also  given in E.R. Stiehm and M.A.Keller (2001) Breast milk transmission of viral disease. Advances in Nutrition Research. 10, 105-122.

Human milk on the world-wide web


Content Approved by: John T. May
Page maintained by: Craig Lighton
Last Updated: 18 June 2007



Related Links

Table 1
Table 2
Table 3
Table 4
Table 5
Table 6
Table 7
Milk in the News


 Search         Contact Microbiology      Sitemap 
Accessibility   Privacy   Copyright © 2005 La Trobe University